Vascular risk factors for Alzheimer's disease: An epidemiologic perspective

Neurobiology of Aging

Volumn 21, Issue 2, 2000, Pages 153-160

  Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alcohol; Alzheimer's disease; APOE; Atherosclerosis; Atrial fibrillation; Dementia; Diabetes; Epidemiology; Hemostatis; Homocysteine; Hypertension; Smoking

Indexed keywords

ALCOHOL; APOLIPOPROTEIN E; CHOLESTEROL; HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INFLAMMATION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STROKE; THROMBOSIS; VASCULAR DISEASE;

ALZHEIMER DISEASE; HUMANS; RISK FACTORS;

EID: 0034603520     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(99)00110-4     Document Type: Conference Paper

References (98)

1. Andersen K., Launer L.J., Ott A., Hoes A.A.W., Breteler M.M.B., Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology. 45:1995;1441-1445.
2. Cardiogenic dementia. Lancet. i:1997;27-28.
3. The Canadian study of health and aging risk factors for Alzheimer's disease in Canada . Neurology. 44:1994;2073-2080.
4. Aronson M.K., Ooi W.L., Morgenstern H., Hafner A., Masur D., Crystal H., Frishman W.H., Fisher D., Katzman R. Women, myocardial infarction, and dementia in the very old. Neurology. 40:1990;1102-1106.
5. Bertina R.M., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., van der Velden P.A., Reitsma P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
6. Berwanger C.S., Jeremy J.Y., Stansby G. Homocysteine and vascular disease. Br J Surg. 82:1995;726-731.
7. Blennow K., Wallin A., Fredman P., Karlsson I., Gottfries C.G., Svennerholm L. (1990) Blood-brain barrier disturbance in patients with Alzheimer's diseases related to vascular factors. Acta Neurol Scand. 81:1990;323-326.
8. Bots M.L., van Kooten F., Breteler M.M.B., Slagboom P.E., Hofman A., Haverkate F., Meijer P., Koudstaal P.J., Grobbee D.E., Kluft C. Response to activated protein C in subjects with and without dementia. The Dutch vascular factors in dementia study. Haemostasis. 28:1998;209-215.
9. Bots M.L., Breteler M.M.B., van Kooten F., Haverkate F., Meijer P., Koudstaal P.J., Grobbee D.E., Kluft C. Coagulation and fibrinolysis markers and risk of dementia. The Dutch vascular factors in dementia study. Haemostasis. 28:1998;216-222.
10. Bots M.L., Launer J.L., Lindemans J., Hoes A.A.W., Hofman A., Witteman J.C.M., Koudstaal P.J., Grobbee D.E. Homocysteine and short term risk of myocardial infarction and stroke in the elderly the Rotterdam study . Arch Intern Med. 159:1999;38-44.
11. Breitner J.C., Gau B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J., Anthony J.C. Inverse association of anti-inflammatory treatments and Alzheimer's disease initial results of a co-twin control study . Neurology. 44:1994;227-232.
12. Brenner D.E., Kukull W.A., van Belle G., Bowen J.D., McCormick W.C., Teri L., Larson E.B. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology. 43:1993;293-300.
13. Breteler M.M.B., Claus J.J., Grobbee D.E., Hofman A. Cardiovascular disease and the distribution of cognitive function in an elderly population. The Rotterdam Study. Brit Med J. 308:1994;1604-1608.
14. Breteler M.M.B., Claus J.J., Launer L.J., van Duijn C.M., Hofman A. Epidemiology of Alzheimer's disease. Epidemiol Rev. 14:1992;59-82.
15. Breteler M.M.B., Mehta K., Ott A., Witteman J.C.M., Hofman A. Alcohol consumption and dementia. The Rotterdam Study. (Abstract) J Neurol. 244:1997;S47.
16. Breteler M.M.B., van Duijn C.M., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Jorm A.F., Kokmen E., Kondo K., Mortimer J.A., Rocca W.A., Shalat S.L., Soininen H., Hofman A. Medical history and Alzheimer's disease. Int J Epidemiol. 20:1991;S36-S42.
17. Bucht G., Adolfsson R., Lithner R., Winblad B. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand. 213:1983;387-392.
18. Cacciatore F., Abete P., Ferrara N., Paolisso G., Amato L., Canonico S., Maggi S., Varricchio M., Rengo F. (1997) The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group. J Hypertens. 15:1997;135-142.
19. Carmel R., Gott P.S., Waters C.H., Cairo K., Green R., Bondareff W., DeGiorgio C.M., Cummings J.L., Jacobsen D.W., Buckwalter G., et al. The frequently low cobalamon levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol. 54:1995;245-253.
20. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 55:1998;1449-1455.
21. Cunha U.G., Rocha F.L., Peixoto J.M., Motta M.F., Barbosa M.T. Vitamin B12 deficiency and dementia. Int Psychogeriatr. 7:1995;85-88.
22. Curb J.D., Rodrigues B.L., Abbott R.D., Petrovitch H., Ross G.W., Masaki K.H., Foley D., Blanchette P.L., Harris T., Chen R., White L.R. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology. 52:1999;971-975.
23. Danesh J., Lewington S. Plasma homocysteine and coronary heart disease systematic review of published epidemiological studies . J Cardiovasc Risk. 5:1998;229-232.
24. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
25. De Knijff P., van Duijn C.M. Role of APOE in dementia a critical reappraisal . Haemostasis. 28:1998;195-201.
26. Eikelenboom P., Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol Aging. 17:1996;673-680.
27. Farmer M.E., White L.R., Abbott R.D., Kittner S.J., Kaplan E., Wolz M.M., Brody J.A., Wolf P.A. Blood pressure and cognitive performance. The Framingham Study. Am J Epidemiol. 126:1987;1103-1114.
28. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimers Disease Meta Analysis Consortium. J Am Med Assoc. 278:1997;1349-1356.
29. Forette F., Seux M.L., Staessen J.A., Thijs L., Birkenhager W.H., Babarskiene M.R., Babeanu S., Bossini A., Gil-Extremera B., Girerd X., Laks T., Lilov E., Moisseyev V., Tuomilehto J., Vanhanen H., Webster J., Yodfat Y., Fagard R. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 352:1998;1347-1351.
30. Forster D.P., Newens A.J., Kay D.W., Edwardson J.A. Risk factors in clinically diagnosed presenile dementia of the Alzheimer type a case-control study in northern England . J Epidemiol Comm Health. 49:1995;253-258.
31. Fratiglioni L., Ahlbom A., Viitanen M., Winblad B. Risk factors for late-onset Alzheimer's disease a population-based, case-control study . Ann Neurol. 33:1993;258-266.
32. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., Winblad B. Very old women at highest risk of dementia and Alzheimer's disease incidence data from the Kungsholmen Project, Stockholm . Neurology. 48:1997;132-138.
33. Frohlich L., Blum-Degen D., Bernstein H.G., Engelsberger S., Humrich J., Laufer S., Muschner D., Thalheimer A., Turk A., Hoyer S., Zochling R., Boissl K.W., Jellinger K., Riedere P. Brain insulin and insulin receptors in aging sporadic Alzheimer's disease. J Neural Transm. 105:1998;423-438.
34. Giubilei F., Antona R., Antonini R., Lenzi G.L., Ricci G., Fieschi C. Serum lipoprotein pattern variations in dementia and ischemic stroke. Acta Neurol Scand. 81:1990;84-86.
35. Graves A.B., van Duijn C.M., Chandra V., Fratiglioni L., Heyman A., Jorm A.F., Kokmen E., Kondo K., Mortimer J.A., Rocca W.A., Shalat S.L., Soininen H., Hofman A. Alcohol and tobacco consumption as risk factors for Alzheimers disease a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group . Int J Epidemiol. 20:1991;S48-S57.
36. Guo Z., Viitanen M., Fratiglioni L., Winblad B. Low blood pressure and dementia in elderly people the Kungsholmen project . Brit Med J. 312:1996;805-808.
37. Haan M.N., Shemanski L., Jagust W.J., Manolio T.A., Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. J Am Med Assoc. 282:1999;40-46.
38. Hebert L.E., Scherr P.A., Beckett L.A., Funkenstein H.H., Albert M.S., Chown M.J., Evans D.A. Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol. 135:1992;347-355.
39. Hofman A., Ott A., Breteler M.M.B., Bots M.L., Slooter A.J.C., van Harskamp F., van Duijn C.M., van Broeckhoven C., Grobbee D.E. Atherosclerosis, apolopoprotein-E and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 349:1997;151-154.
40. Itzhaki R.F., Lin W.R., Shang D., Wilcock G.K., Faragher B., Jamieson G.A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 349:1997;241-244.
41. Jarvik G.P., Wijsman E.M., Kukull W.A., Schellenberg G.D., Yu C., Larson E.B. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimers disease a case-control study . Neurology. 45:1995;1092-1096.
42. Joosten E., Lesaffre E., Riezler R., Ghekiere V., Dereymaeker L., Pelemans W., Dejaeger E. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol. 52:1997;76-79.
43. Kalmijn S., Launer L.J., Lindemans J., Bots J.L., Hofman A., Breteler M.M.B. Total homocysteine and cognitive decline in a community-based sample of elderly subjects the Rotterdam Study . Am J Epidemiol. 150:1999;283-289.
44. Kalmijn S., Launer L.J., Ott A., Witteman J.C.M., Hofman A., Breteler M.M.B. Dietary fat intake and the risk of dementia in a population-based study the Rotterdam Study . Ann Neurol. 42:1997;776-782.
45. Kilander L., Andren B., Nyman H., Lind L., Boberg M., Lithell H. Atrial fibrillation is an independent determinant of low cognitive function a cross-sectional study in elderly men . Stroke. 29:1998;1816-1820.
46. Kilander L., Nyman H., Boberg M., Hansson L., Lithell H. Hypertension is related to cognitive impairment a 20-year follow-up of 999 men . Hypertension. 31:1998;780-786.
47. Kontula K., Ylikorlala A., Miettinen H., Vuorio A., Kauppinen-Mäkelin R., Hämäläinen L., Palomaki H., Kaste M. Arg506Gln factor V mutation in patients with ischemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost. 73:1995;558-560.
48. Koster T., Rosendaal F.R., Ronde H., Briet E., Vandenbroucke J.P., Bertina R.M. Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden Thrombophilia Study. Lancet. 342:1993;1503-1506.
49. Landin K., Blennow K., Wallin A., Gottfries C.G. Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder? J Intern Med. 233:1993;357-363.
50. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. J Am Med Assoc. 274:1995;1846-1851.
51. Lee P.N. Smoking and Alzheimer's disease a review of the epidemiological evidence . Neuroepidemiology. 13:1994;131-144.
52. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brian P.C., Palumbo P.J. Risk of dementia among persons with diabetes mellitus a population-based cohort study . Am J Epidemiol. 145:1997;301-308.
53. Letenneur L., Dartigues J.F., Commenges D., Burberger-Gateau P., Tessier J.F., Orgogozo J.M. Tobacco consumption and cognitive impairment in elderly people. A population-based study. Ann Epidemiol. 4:1994;449-454.
54. Leys D., Pasquier F. Prevention of dementia Syst-EUR trial. Correspondence . Lancet. 353:1999;235-237.
55. Mahley R.W. Apolipoprotein E cholesterol transport protein with expanding role in cell biology . Science. 240:1988;622-630.
56. McGeer P.J., McGeer E.G. The inflammatory response system of brain implications for therapy of Alzheimer and other neurodegenerative diseases . Brain Res Brain Res Rev. 21:1995;195-218.
57. Messier C., Gagnon M. Glucose regulation and cognitive functions relation to Alzheimer's disease and diabetes . Behav Brain Res. 75:1996;1-11.
58. Mortel K.F., Wood S., Pavol M.A., Meyer J.S., Rexer J.L. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease. Angiology. 44:1993;599-605.
59. Munch G., Cunningham A.M., Riederer P., Braak E. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease. Brain Res. 796:1998;307-310.
60. Newhouse P.A., Potter A., Corwin J., Lenox R. Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology. 10:1994;93-107.
61. Nielson K.A., Nolan J.H., Brechtold N.C., Sandman C.A., Mulnard R.A., Cotman C.W. Apolopoprotein-E genotyping of diabetic dementia patients is diabetes rare in Alzheimer's disease? J Am Geriatr Soc. 44:1996;897-904.
62. Nilsson K., Gustafson L., Faldt R., Andersson A., Brattstrom L., Lindgren A., Israelsson B., Hultberg B. Hyperhomocysteinaemia-a common finding in a psychogeriatric population. Eur J Clin Invest. 26:1996;853-859.
63. Nitta A., Katono Y., Itoh A., Hasegawa T., Nabeshima T. Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system. Pharmacol Biochem Behav. 49:1994;807-812.
64. Notkola I.L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., Nissinen A. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology. 17:1998;14-20.
65. O'Connell J.E., Gray C.S., French J.M., Robertson I.H. Atrial fibrillation and cognitive function case-control study . J Neurol Neurosurg Psychiatry. 65:1998;386-389.
66. Orgogozo J.M., Dartigues J.F., Lafont S., Letenneur L., Commenges D., Salamon R., Renaud S., Breteler M.M.B. Wine consumption and dementia in the elderly a prospective community study in the Bordeaux area . Rev Neurol (Paris). 153:1997;185-192.
67. Ott A., Breteler M.M.B., de Bruyne M.C., van Harskamp F., Grobbee D.E., Hofman A. Atrial Fibrillation and dementia in a Population-Based Study. The Rotterdam Study. Stroke. 28:1997;316-321.
68. Ott A., Breteler M.M.B., van Harskamp F., Stijnen T., Hofman A. The incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol. 197:1998;574-580.
69. Ott A., Slooter A.J.C., Hofman A., van Harskamp F., Witteman J.C.M., van Broeckhoven C., van Duijn C.M., Breteler M.M.B. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study the Rotterdam Study . Lancet. 351:1998;1840-1843.
70. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., Breteler M.M.B. Association of diabetes mellitus and dementia the Rotterdam study . Diabetologia. 39:1996;1392-1397.
71. Ott A., Stolk R.P., van Harskamp F., Pols H.A.P., Hofman A., Breteler M.M.B. Diabetes mellitus and the risk of dementia in a elderly population. The Rotterdam Study. Neurology. 53:1999;1907-1909.
72. Perry I.J., Refsum H., Morris R.W., Ebrahim S.B., Ueland P.M., Shaper A.G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1995;1395-1398.
73. Poirier J., Delisle M.C., Quirion R., Aubert I., Farlow M., Lahiri D., Hui S., Bertrand P., Nalbantoglu J., Gilfix B.M. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc Natl Acad Sci USA. 92:1995;12260-12264.
74. Prince M., Cullen M., Mann A. Risk factors for Alzheimer's disease and dementia a case-control study based on the MRC elderly hypertension trial . Neurology. 44:1994;97-104.
75. Ridker P.M., Hennekens C.H., Lindpainter K., Stampfer M.J., Eisenberg P.R., Miletich J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med. 332:1995;912-917.
76. Riggs J.E. Smoking and Alzheimer's disease protective effect or differential survival bias? Lancet. 342:1993;793-794.
77. Riggs K.M., Spiro A. III, Tucker K., Rush D. Relations of vitamine B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 63:1996;306-314.
78. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126.
79. Sasaki N., Fukatsu R., Tsuzuki K., Hayashi Y., Yoshida T., Fujii N., Koike T., Wakayama I., Yanagihara R., Garruto R., Amano N., Makita Z. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol. 153:1998;1149-1155.
80. Saunders P.A., Copeland J.R., Dewey M.E., Davidson I.A., McWilliam C., Sharma V., Sullivan C. Heavy drinking as a risk factor for depression and dementia in elderly men. Finding from the Liverpool longitudinal study. Br J Psychiatry. 159:1991;213-216.
81. Scherr P.A., Hebert L.E., Smith L.A., Evans D.A. Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol. 134:1991;1303-1315.
82. Skoog I., Andreasson L.A., Landahl S., Lernfelt B. A population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension. 32:1998;404-409.
83. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., Persson G., Oden A., Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 347:1996;1141-1145.
84. Slooter A.J.C., van Duijn C.M. Genetic epidemiology of Alzheimer's disease. Epidemiol Rev. 19:1997;107-119.
85. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. J Am Med Assoc. 277:1997;813-817.
86. Sparks D.L., Scheff S.W., Hunsaker J.C. III, Liu H., Landers T., Gross D.R. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol. 126:1994;8-94.
87. Sparks D.L., Scheff S.W., Liu H., Landers T.M., Coyne C.M., Hunsaker J.C. III. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci. 131:1995;162-169.
88. Starr J.M., Whalley L.J., Inch S., Shering P.A. Blood pressure and cognitive function in healthy old people. J Am Geriatr Soc. 41:1993;753-756.
89. Strittmatter W.J., Saunders A.M., Schemechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease . Proc Natl Acad Sci USA. 90:1993;1977-1981.
90. Svensson P.J., Dahlback B. Resistance to activated protein C as a basis for veneous thrombosis. N Engl J Med. 330:1994;517-522.
91. Teunisse S., Bollen A.E., van Gool W.A., Walstra G.J. Dementia and subnormal levels of vitamin B12 effects of replacement therapy on dementia . J Neurol. 243:1996;522-529.
92. Van Bockxmeer F.M., Mamotte C.D.S. Apolipoprotein ε4 homozygos-ity in young men with coronary heart disease. Lancet. 340:1992;879-880.
93. Van Dam A.M., de Vries H.E., Kuiper J., Zijlstra F.J., de Boer A.G., Tilders F.J., Berkenbosch F. Interleukin-1 receptors on rat brain endothelial cells a role in neuroimmune interaction? FASEB J. 10:1996;351-356.
94. Van Duijn C.M. Epidemiology of the dementias recent developments and new approaches . J Neurol Neurosurg Psych. 60:1996;478-488.
95. Van Duijn C.M., Havekes L.M., van Broeckhoven C., de Knijff P., Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ. 310:1995;627-631.
96. Wang H.X., Fratiglioni L., Frisoni G.B., Viitanen M., Winblad B. Smoking and the occurrence of Alzheimer's disease cross-sectional and longitudinal data in a population-based study . Am J Epidemiol. 149:1999;640-644.
97. Wolf-Klein G.P., Siverstone F.A., Brod M.S., Levy A., Foley C.J., Termotto V., Breuer J. Are Alzheimer patients healthier? J Am Geriatr Soc. 36:1988;219-224.
98. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Ohmori S., Nomiyama K., Kawano H., Ueda K. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population the Hisayama Study . Neurology. 45:1995;1161-1168.